IanMartinThompsonMD

PubMed

• 19 citations
  African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer
  Roshan Karunamuni, Minh-Phuong Huynh-Le, Chun Fan, Wesley K. Thompson, Rosalind A. Eeles, Zsofia Kote-Jarai, Kenneth Muir, Artitaya Lophatananon, Catherine M. Tangen, ...> ;International Journal of Cancer. 2021 Jan 1
• Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator.
  Ankerst, D. P.,Xia, J.,Thompson, I. M.,Hoefler, J.,Newcomb, L. F.,Brooks, J. D.,Carroll, P. R.,Ellis, W. J.,Gleave, M. E.,Lance, R. S.,Nelson, P. S.,Wagner, A. A.,Wei,...> ;Eur. Urol.. 2015 Mar 31
• Processing of voided urine for prostate cancer RNA biomarker analysis.
  Quek, S. I.,Wong, O. M.,Chen, A.,Borges, G. T.,Ellis, W. J.,Salvanha, D. M.,Vêncio, R. Z.,Weaver, B.,Ench, Y. M.,Leach, R. J.,Thompson, I. M.,Liu, A. Y.> ;Prostate. 2015 Aug 27
• Evaluating Intermittent Androgen-Deprivation Therapy Phase III Clinical Trials: The Devil Is in the Details.
  Hussain, M.,Tangen, C.,Higano, C.,Vogelzang, N.,Thompson, I.> ;J. Clin. Oncol.. 2015 Nov 11
• Effect of Finasteride on Serum Androstenedione and Risk of Prostate Cancer Within the Prostate Cancer Prevention Trial: Differential Effect on High- and Low-grade Dise...
  Hoque, A.,Yao, S.,Till, C.,Kristal, A. R.,Goodman, P. J.,Hsing, A. W.,Tangen, C. M.,Platz, E. A.,Stanczyk, F. Z.,Reichardt, J. K.,vanBokhoven, A.,Neuhouser, M. L.,Sant...> ;Urology. 2015 Mar 04
• Response.
  Brasky, T. M.,Thompson, I. M.,King, I. B.,Kristal, A. R.> ;J. Natl. Cancer Inst.. 2014 Apr 02
• Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial.
  Brasky, T. M.,Darke, A. K.,Song, X.,Tangen, C. M.,Goodman, P. J.,Thompson, I. M.,Meyskens, F. L.,Goodman, G. E.,Minasian, L. M.,Parnes, H. L.,Klein, E. A.,Kristal, A. R.> ;J. Natl. Cancer Inst.. 2013 Aug 7
• 1 citations
  When and how do we get involved in prostate cancer prevention
  Ian M. Thompson> ;Urology. 2010 Mar 1
• Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinic...
  Thompson, I. M.,Tangen, C. M.,Paradelo, J.,Lucia, M. S.,Miller, G.,Troyer, D.,Messing, E.,Forman, J.,Chin, J.,Swanson, G.,Canby-Hagino, E.,Crawford, E. D.> ;J. Urol.. 2009 Jan 27
• 80 citations
  Fusion rate of first tarsometatarsal arthrodesis in the modified Lapidus procedure and flatfoot reconstruction.
  Ian Thompson, Donald R. Bohay, John G. Anderson> ;Foot & Ankle International. 2005 Sep 1
• 2 citations
  Editorial: Prostate Cancer
  Ian M. Thompson> ;The Journal of Urology. 1997 Mar 1
• 24 citations
  Clinical reviewChemoprevention of prostate cancer
  Otis W. Brawley, Ian M. Thompson> ;Urology. 1994 May 1
• UroradiologyCoronal renal ultrasound: II
  Ian M. Thompson, Alexander Kovac, John Geshner> ;Urology. 1981 Feb 1
• Join now to see all